Erythrocyte fragility changes produced by sulfanilamide

[1] DAVIS HA, 1938, ARCH PATH, V25, P750

[2] Increased urobilinogen excretion and acute hemolytic anemia in patients treated with sulfapyridine [J]. JOURNAL OF CLINICAL INVESTIGATION, 1940, 19 (03) : 451 - 458

[3] Hageman PO, 1937, P SOC EXP BIOL MED, V37, P119

[4] KLEMPERER P, 1936, AM J CLIN PATHOL, V6, P99

[5] MACHELLA T. E., 1939, PROC STAFF MEETINGS MAYO CLINIC, V14, P183

[6] Anemia induced in rats by means of sulphanilamide [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1939, 198 (06) : 804 - 815

[7] Molitor H, 1939, J PHARMACOL EXP THER, V65, P405

[8] MURAYAMA F, 1938, J PHARMACOL EXP THER, V63, P29

[9] Richardson AP, 1939, J PHARMACOL EXP THER, V67, P429

[10] Rimington C, 1938, LANCET, V1, P770

[1] DAVIS HA, 1938, ARCH PATH, V25, P750

[2] Increased urobilinogen excretion and acute hemolytic anemia in patients treated with sulfapyridine [J]. JOURNAL OF CLINICAL INVESTIGATION, 1940, 19 (03) : 451 - 458

[3] Hageman PO, 1937, P SOC EXP BIOL MED, V37, P119

[4] KLEMPERER P, 1936, AM J CLIN PATHOL, V6, P99

[5] MACHELLA T. E., 1939, PROC STAFF MEETINGS MAYO CLINIC, V14, P183

[6] Anemia induced in rats by means of sulphanilamide [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1939, 198 (06) : 804 - 815

[7] Molitor H, 1939, J PHARMACOL EXP THER, V65, P405

[8] MURAYAMA F, 1938, J PHARMACOL EXP THER, V63, P29

[9] Richardson AP, 1939, J PHARMACOL EXP THER, V67, P429

[10] Rimington C, 1938, LANCET, V1, P770